Fast-acting impotency drug outpaces rivals: study (AFP)
AFP – Biotech firm Vivus unveiled a would-be player Monday in the 3.7-billion-dollar erectile dysfunction market: avanafil, effective in just 15 minutes, far faster than blockbuster rivals Viagra and Cialis.
Continued here:
Fast-acting impotency drug outpaces rivals: study
(AFP)
Filed Under: Canadian Biotech
Tags: afp, biotech, erectile-dysfunction, far-faster, health, monday, the-3-7-billion-dollar, vivus
Comments
No Comments
Leave a reply